Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$56.61 - $80.46 $573,402 - $814,979
-10,129 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $27,593 - $40,060
320 Added 3.26%
10,129 $941,000
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $1,662 - $2,340
21 Added 0.21%
9,809 $879,000
Q3 2020

Nov 12, 2020

SELL
$81.91 - $134.94 $10,484 - $17,272
-128 Reduced 1.29%
9,788 $1.01 Million
Q2 2020

Aug 12, 2020

BUY
$54.33 - $89.52 $538,736 - $887,680
9,916 New
9,916 $784,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Renaissance Group LLC Portfolio

Follow Renaissance Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.